scispace - formally typeset
L

Liju Ahmed

Researcher at Guy's and St Thomas' NHS Foundation Trust

Publications -  25
Citations -  452

Liju Ahmed is an academic researcher from Guy's and St Thomas' NHS Foundation Trust. The author has contributed to research in topics: Malignant pleural effusion & Pleurodesis. The author has an hindex of 9, co-authored 23 publications receiving 313 citations. Previous affiliations of Liju Ahmed include King's College & King's College London.

Papers
More filters
Journal ArticleDOI

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

TL;DR: Among patients without substantial lung entrapment, the outpatient administration of talc through an indwelling pleural catheter for the treatment of malignant pleural effusion resulted in a significantly higher chance of pleurodesis at 35 days than an ind welling catheter alone, with no deleterious effects.
Journal ArticleDOI

Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.

TL;DR: In this article, the authors used an open-label, randomized clinical trial at 17 UK hospitals to test the hypothesis that talc poudrage during thoracoscopy with local anesthesia is more effective than talc slurry delivered via chest tube in successfully inducing pleurodesis.
Journal ArticleDOI

Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway

TL;DR: The safety and efficacy of administering talc slurry through IPCs in an outpatient setting is confirmed and studies in a larger cohort are necessary to define the role of this novel approach in the treatment algorithm of patients with this condition.
Journal ArticleDOI

OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management

TL;DR: The OPTIMUM trial is designed to determine whether full outpatient management of malignant pleural effusion with an indwelling pleural catheter (IPC) and pleurodesis improves quality of life (QoL) compared with traditional inpatient care with a chest drain and talc pleurdesis.
Journal ArticleDOI

Safety of indwelling pleural catheter use in patients undergoing chemotherapy: a five-year retrospective evaluation

TL;DR: This is the second largest retrospective case–control series that concludes systemic chemotherapy is safe in patients with IPC undergoing chemotherapy.